Donor pretreatment in cardiac allografts

R. Nowygrod, M. A. Hardy, G. J. Todd, S. Oluwole, K. Reemtsma

Producción científicarevisión exhaustiva

2 Citas (Scopus)

Resumen

Prolongation of allograft survival by donor treatment prior to transplantation has a sound experimental base and has had promising early clinical results. We report the effects of pretreatment with cyclophosphamide, antilymphocyte globulin (ALG), and graft perfusion on rat heart allograft survival and passenger lymphocyte depletion and the results of cyclophosphamide and methylprednisolone pretreatment on T-cell function in cadaveric human heart donors.

Idioma originalEnglish
Páginas (desde-hasta)1462-1464
Número de páginas3
PublicaciónTransplantation Proceedings
Volumen11
N.º2
EstadoPublished - 1979

ASJC Scopus Subject Areas

  • Surgery
  • Transplantation

Huella

Profundice en los temas de investigación de 'Donor pretreatment in cardiac allografts'. En conjunto forman una huella única.

Citar esto